{
  "id": 21193225,
  "title": "$1,000 Invested in Eli Lilly 5 Years Ago Is Now Worth Over $5,000. Could It Soar That Much Again by 2031?",
  "url": "https://urgent.news/2026/11/22/1-000-invested-in-eli-lilly-5-years-ago-is-now-worth-over-5-000-could",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-22T09:10:00.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/11/22/1000-invested-in-eli-lilly-5-years-ago-is-now-wort/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "Investing $1,000 in Eli Lilly five years ago would now yield over $5,000, and the company's growth potential could continue into 2031. Lilly specializes in treatments, particularly in the weight loss drug sector where it has seen impressive double-digit revenue growth. Their GLP-1 drugs, Mounjaro and Zepbound, have proven effective and are self-administered, leading to increased demand. Despite not being the original leader in GLP-1 drugs, Lilly has surged ahead, and a recent earnings report highlights the power of its weight loss portfolio, with Mounjaro and Zepbound driving significant revenue growth. The company also boasts a robust pipeline of weight loss drug candidates, including a promising pill, Retatrutide, in phase 3 trials. With a potential gain of around 420%, Lilly's share price could rise to $7,092 and its market cap to $6.3 trillion, surpassing the value of major technology leaders. While other sectors may also experience growth, Lilly's unique position and potential for gains make it an attractive investment option.",
  "summary": "The pharma giant offers investors a mix of safety and growth.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}